Zydena on Cognitive Function of Alzheimer's Disease Patients
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Zydena (Udenafil) has positive effect on
cognitive function in patients with Alzheimer's disease.
This study is a randomized, double blind, placebo-controlled multicenter study.